Data-independent acquisition mass spectrometry in severe rheumatic heart disease (RHD) identifies a proteomic signature showing ongoing inflammation and effectively classifying RHD cases

2018-2022
Written By RRCU Staff

Download the PDF

Salie MT, Yang J, Ramirez Medina CR, Zuhlke LJ, Chishala C, Ntsekhe M, Gitura B, Ogendo S, Okello E, Lwabi P, Musuku J, Mtaja A, Hugo-Hamman C, El-Sayed A, Damasceno A, Mocumbi A, Bode-Thomas F, Yilgwan C, Amusa GA, Nkereuwem E, Shaboodien G, Da Silva R, Lee DCH, Frain S, Geifman N, Whetton AD, Keavney B, Engel ME and Consortium RHN. Data-independent acquisition mass spectrometry in severe rheumatic heart disease (RHD) identifies a proteomic signature showing ongoing inflammation and effectively classifying RHD cases.

Clin Proteomics. 2022;19:7.

RRCU Staff
Previous

Clinical outcomes of children with rheumatic heart disease
Next

Modelling study of the ability to diagnose acute rheumatic fever at different levels of the Ugandan healthcare system